BioLeaders

Helen Slaski BioLeader Interview - Helen Slaski, Chief Executive Officer Cambridge Science Centre (October 2021) Qualifying as a Pharmacist from London School of Pharmacy (now UCL) and specialising in Pharmaceutical Engineering Sciences, I started my working career with GSK in operations management, moving to international production support and subsequently as Executive Assistant to the Group Technical Director.   Escaping to complete an MBA at London Business School, I have since had forays into strategic consultancy, newspaper and magazine publishing, FMCG manufacturing, medical device design and development and an organisation of international language schools. I was thrilled to join Cambridge Science [...]

Fiona Nielsen BioLeader Interview - Fiona Nielsen, Chief Operating Officer at o2h Technology (October 2021) Fiona Nielsen is the Chief Operating Officer at o2h Technology, the software services arm of o2h Group. The o2h Technology team of expert engineers are specialised in building web and mobile app MVPs for start-ups primarily in life sciences, health tech and green tech. Fiona got her degrees in computer science and bioinformatics in Denmark and the Netherlands. She moved to Cambridge to specialise in genomics and next-generation sequencing, working for Illumina. She left Illumina to found the charity DNAdigest and the company Repositive [...]

Alex Leech BioLeader Interview - Alex Leech, Chair at 2N Pharma, Company Builder and CEO (September 2021) An experienced company creator and CEO with a successful track record. Key milestones in your career journey to date? As CEO, raising $82m in 2020 for Alchemab, which we built in 16 months from a standing start; as a result of having a world-class team and a great concept.  This and our timing created a great UK company and strong investment opportunity. Leading Creabilis between 2015-2017, as CEO; with the remit to exit; during which we explored listing and ultimately sold the [...]

Barbara Domayne-Hayman BioLeader Interview - Barbara Domayne-Hayman, Entrepreneur-in-Residence at The Francis Crick Institute and Board Director (August 2021) I am a company builder and deal-maker in biotech, who has successfully transitioned from working in large organisations to an entrepreneurial environment and mindset. I want to make a real contribution to society through the commercialisation of new science. I also have a passion for opera and playing the harp and piano. Key milestones in your career journey to date? I received amazing support from my parents to pursue whatever career route I chose - which was initially a difficult decision [...]

Dr. David Atkins BioLeader Interview - Dr. David Atkins, CEO Congenica (August 2021) Accomplished global healthcare leader with strong emerging markets experience in a broad range of medical device sectors and specialty clinical services. Expertise includes clinical and molecular diagnostics, anatomic pathology, wound management, minimally invasive and general surgery, orthopaedics, sterilisation, aesthetics and cellular diagnostics. Business leadership Internationally in US, Canada, EU, Emerging Markets (Middle East, Africa, Asia, Latin America). Start-up ventures, turnaround and high-growth enterprise expertise. Broad functional expertise in sales and marketing, R&D pipeline, product development, QRC and operations and business development. Key milestones in your career [...]

Dr. Kevin Pojasek BioLeader Interview - Dr. Kevin Pojasek, CEO Enara Bio (July 2021) Dr. Pojasek is a biotech executive with nearly 20 years’ experience founding and leading companies in the US and UK. Dr. Pojasek is currently President and CEO of Enara Bio, as well as Founder and Director of Catamaran Bio and Venture Partner for SV Health Investors. Prior to joining SV, Dr. Pojasek was Chief Strategy and Business Officer and a member of the executive leadership team at Immunocore Ltd. Prior to joining Immunocore, Dr. Pojasek was President, Chief Executive Officer of Quartet Medicine, a company [...]

Nazneen Rahman BioLeader Interview - Dr Nazneen Rahman, Founder & CEO YewMaker, NED AstraZeneca (June 2021) Nazneen Rahman CBE, MD, PhD, FRCP, FMedSci Nazneen Rahman has made significant contributions to science and medical research over the last 25 years. She is an internationally recognised expert in cancer genomics and was Professor of Human Genetics at the Institute of Cancer Research and Head of Cancer Genetics at the Royal Marsden Hospital, London until 2018. Nazneen is a Non-Executive Director at AstraZeneca, Chair of the AstraZeneca Science Committee and oversees Sustainability for the Board. Nazneen is now focussed on making healthcare [...]

Peter Joyce BioLeader Interview - Peter Joyce (April 2021) Peter Joyce is Co-founder and Chief Executive Officer of Grey Wolf, having founded the Company in 2017 with Tom McCarthy. Prior to Grey Wolf Peter was at Vertex Pharmaceuticals where he led drug discovery projects, had responsibility for leading a number of target identification teams that led to multiple novel drug discovery projects and was involved in delivering clinical drug candidates. Peter has a broad scientific experience across therapeutic areas having worked on projects in oncology, genetic diseases and neurodegeneration. He also pioneered the development of complex neurological assays suitable [...]

Eric Mayes BioLeader Interview - Eric Mayes (April 2021) Dr Eric Mayes is CEO of Endomag and has over 20 years’ experience in developing and leading materials technology companies spanning data storage, display technology, printed electronics and medical devices. Eric has led oncology-focused Endomag through its rapid growth since marketing its first device for staging breast cancer in late 2012. The company has now helped over 130,000 patients receive a higher standard of care in over 550 hospitals across 43 countries. Prior to joining Endomag in 2010, Eric served as Director of Commercial Development for Cambridge Display Technology (CDT) [...]

Huw Jones BioLeader Interview - Huw Jones (March 2021) For over 20 years, Huw Jones has been a serial CEO and NED of early stage and listed biotech companies. Throughout his varied career he has launched dozens of new medicines, in several countries, completed tens of M&A transactions and managed many drug development programmes. He was appointed CEO of Evgen Pharma PLC, in October 2020, an AIM listed, clinical stage cancer and inflammation company. He recently led the raise of £10m in a placing and up to a further £1m in an open offer in a heavily oversubscribed and [...]